Fig. 2From: Could potentially calprotectin be a promising biomarker to oracle biologic therapy response in rheumatoid arthritis?Box and Whisker plot of serum calprotectin before and after therapy among rheumatoid arthritis patients. Three months after biologic therapy, a significant decline in serum calprotectin from 404.1 (60.0–908.2 ng/ml) to 131.70 (39.9–171.73 ng/ml) was observed (P < 0.001)Back to article page